Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
about
Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancerPotential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthmaThe duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanismAlternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protectionProlonged expression of MHC class I - peptide expression in bone marrow derived retrovirus transfected matured dendritic cells by continuous centrifugation in the presence of IL-4.T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer.Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice.Gene transfer approaches in cancer immunotherapy.Human cancer gene therapy with cytokine gene-modified cells.Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction.Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in miceLeukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.Spontaneous rejection of intradermally transplanted non-engineered tumor cells by neutrophils and macrophages from syngeneic strains of mice.Renal transplant fine needle aspiration and cytokine gene expression.Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.The potential applications of gene transfer in the treatment of patients with cancer: a concise review.A model for cancer-suppressive inflammationTumor immunotherapy by vaccination with cytokine gene transfected cells.Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.Tumor-related interleukins: old validated targets for new anti-cancer drug development.Expression of interleukin 10 in human melanoma.Tumor rejection by disturbing tumor stroma cell interactions.Tumor rejection by modulation of tumor stromal fibroblasts.Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression.Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.A novel paradigm for dendritic cells as effectors of cartilage destruction.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis.
P2860
Q26865509-A51E3FE4-F5D2-4351-83CB-B858521CA2FBQ33775800-E6A6D4FB-4DAF-42A3-B98A-DB70D15F1DE8Q34003186-0AF8F044-4D4B-4ADC-BF6B-C8B6660F7F15Q34392868-FAFBEC43-B66B-45F1-ADEE-07FDA3A2A9E1Q34619781-9B443F43-82CE-479E-A115-EBD2F470CAC0Q34982602-8D369EA3-F84A-4218-89C5-4803F839F568Q35636865-17878427-955A-42E9-B1CE-8DD9D01318DDQ35646910-F7CE27D2-231C-4478-9614-8556A4117EB1Q35764397-21751269-26C0-48AC-8D99-0032AA154C03Q35796105-978D1DAE-CCCA-4217-9E5A-500FA4E07C39Q35889174-4BF9DF47-CC22-4AEC-88F5-ECD3D4E63094Q35904413-19B4A290-B102-4F43-BE82-FC7643F0D294Q35907018-8BA3C82E-E835-4C0D-BBD1-A3C849C7E545Q36136494-7DFA785F-6865-4090-B500-AEE8015B7EE7Q36292705-11B76B11-79FF-4B13-9079-B177D784A7B3Q36361923-339DA28B-437D-4FAF-9067-40AA8958F602Q36369691-365D20EF-838F-4063-B43C-FFAB506DE7C6Q36438502-73EF534A-7F00-4643-90B7-AC586836E1D8Q36614375-0047FD5F-194E-4231-B834-A3641E6E3E44Q37352432-149D2996-4D22-41AE-A226-839C20D48FE2Q37366828-5BB40F8C-E334-4EC7-9975-D1DA9360DDEEQ37646545-51C667C6-4AA2-4026-8610-04B12A39AAE6Q37724672-1EE689A7-213B-4B4A-B292-47B0893314F5Q39497120-AE0D9033-4FBB-40F3-A491-395447B96E2CQ40377870-42CC2951-AE39-4ACD-9CB2-0128159241D4Q40624060-0FFB6847-1E8A-440A-B9BD-FEFF2979E825Q41020855-65C819F5-E79C-4076-BF76-F8A696FFE26CQ41275639-6E7F5057-4DC4-4130-8744-7E47E7025544Q41455939-A9337CC3-C20A-4BA5-B118-8EED207D490FQ41493082-9087D2D9-1B22-4EBD-B336-91B9712C63EEQ41716360-1F214B37-8B2A-4014-8B27-F9CD6AA48949Q42067641-68DD2696-86EB-489E-A14E-E5ABB1C7662EQ42944518-A214773B-3291-4681-8772-429ECC9C8D15Q42945088-9AF03DDA-E523-4506-B04D-0CCD6FF4BF1BQ45763976-AA0DB35E-0736-40C0-9321-3E136F05CF55Q45858579-B745940A-8144-4261-9E90-72AB155D3D71Q45862586-A6647716-39AC-4BC5-8DC3-5A0604F9F2BCQ46095815-E3858F12-ABE1-4938-96C1-0D52482DEF28Q47093975-E13DFAD8-3D29-492B-9CCB-FD6F47FC7317Q47144483-56739D68-118E-4790-8791-9D7B536F7D87
P2860
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Mechanisms of rejection induce ...... is factor, or interferon gamma
@ast
Mechanisms of rejection induce ...... is factor, or interferon gamma
@en
type
label
Mechanisms of rejection induce ...... is factor, or interferon gamma
@ast
Mechanisms of rejection induce ...... is factor, or interferon gamma
@en
prefLabel
Mechanisms of rejection induce ...... is factor, or interferon gamma
@ast
Mechanisms of rejection induce ...... is factor, or interferon gamma
@en
P2093
P2860
P356
P1476
Mechanisms of rejection induce ...... is factor, or interferon gamma
@en
P2093
Blankenstein T
Diamantstein T
Kunzendorf U
P2860
P304
P356
10.1073/PNAS.90.7.2774
P407
P577
1993-04-01T00:00:00Z